Literature DB >> 11008896

Contrast sensitivity in patients recovered from central serous chorioretinopathy.

T Maaranen1, M Mäntyjärvi.   

Abstract

OBJECTIVE: To study contrast sensitivity in patients who have recovered from central serous chorioretinopathy (CSC). PATIENTS AND METHODS: Thirty-one patients who had recovered from CSC were examined with the Vistech and Pelli-Robson contrast sensitivity charts. The time from the onset of the active disease varied from 10 to 166 months (mean 60.4 +/- 42.0, SD). The visual acuity was 1.0 (logMar 0) or better.
RESULTS: Contrast sensitivity of the affected eyes was significantly worse in the intermediate spatial frequencies of 3 and 6 cycles per degree (cpd) in the Vistech test compared to the fellow eyes (p = 0.032, 0.013, respectively). Contrast sensitivity of the affected eyes was significantly worse in all 5 spatial frequencies of the Vistech test and in the Pelli-Robson test compared to age-matched normal eyes (p = 0.006, 0.000, 0.000, 0.018, 0.000, 0.000, respectively). Contrast sensitivity of the fellow eyes was significantly worse in the spatial frequencies of 3 and 18 cpd in the Vistech test and in the Pelli-Robson test compared to age-matched normal eyes (p = 0.020, 0.019, 0.000, respectively).
CONCLUSIONS: Contrast sensitivity does not seem to recover in all eyes after CSC even if the visual acuity has returned to normal. Therefore, contrast sensitivity testing is recommended for the patients complaining of visual impairment in spite of good visual acuity.

Entities:  

Mesh:

Year:  1999        PMID: 11008896     DOI: 10.1023/a:1006496615006

Source DB:  PubMed          Journal:  Int Ophthalmol        ISSN: 0165-5701            Impact factor:   2.031


  20 in total

Review 1.  Central serous retinopathy associated with adrenocorticotrophic hormone therapy. A case report and a hypothesis.

Authors:  E Zamir
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1997-06       Impact factor: 3.117

2.  Central visual function in patients with resolved central serous retinopathy. A long term follow-up study.

Authors:  J A Mutlak; G N Dutton; M Zeini; D Allan; A Wail
Journal:  Acta Ophthalmol (Copenh)       Date:  1989-10

3.  Central serous retinopathy and pregnancy.

Authors:  L C Chumbley; R N Frank
Journal:  Am J Ophthalmol       Date:  1974-02       Impact factor: 5.258

4.  Pathogenesis of disciform detachment of the neuroepithelium.

Authors:  J D Gass
Journal:  Am J Ophthalmol       Date:  1967-03       Impact factor: 5.258

5.  Visual disturbances during pregnancy caused by central serous choroidopathy.

Authors:  J R Cruysberg; A F Deutman
Journal:  Br J Ophthalmol       Date:  1982-04       Impact factor: 4.638

6.  Digital indocyanine green videoangiography of central serous chorioretinopathy.

Authors:  D R Guyer; L A Yannuzzi; J S Slakter; J A Sorenson; A Ho; D Orlock
Journal:  Arch Ophthalmol       Date:  1994-08

7.  Central serous choroidopathy in pregnancy.

Authors:  D M Fastenberg; R R Ober
Journal:  Arch Ophthalmol       Date:  1983-07

8.  Central serous chorioretinopathy: some considerations on the pathogenesis.

Authors:  F C Piccolino
Journal:  Ophthalmologica       Date:  1981       Impact factor: 3.250

9.  Contrast sensitivity in macular disease using a small-field and a large-field TV-system.

Authors:  J Sjöstrand
Journal:  Acta Ophthalmol (Copenh)       Date:  1979-10

10.  [Abnormalities of retinal function (light sense) following idiopathic central serous chorioretinopathy and diffuse retinal epitheliopathy].

Authors:  L Beuchat; F Simona; A B Safran
Journal:  Klin Monbl Augenheilkd       Date:  1988-05       Impact factor: 0.700

View more
  4 in total

1.  Choroidal vascular remodelling in central serous chorioretinopathy after indocyanine green guided photodynamic therapy with verteporfin: a novel treatment at the primary disease level.

Authors:  W-M Chan; D S C Lam; T Y Y Lai; B S M Tam; D T L Liu; C K M Chan
Journal:  Br J Ophthalmol       Date:  2003-12       Impact factor: 4.638

2.  A New Side Effect of Intravitreal Dexamethasone Implant (Ozurdex®).

Authors:  Erdem Eris; Gurkan Erdogan; Irfan Perente; Gokhan Demir; Burcin Kepez Yildiz; Ebru Demet Aygit
Journal:  Case Rep Ophthalmol Med       Date:  2017-10-02

3.  Pattern of Contrast Sensitivity Changes in Acute Central Serous Chorioretinopathy.

Authors:  Preeyachan Lourthai; Patama Bhurayanontachai
Journal:  J Ophthalmol       Date:  2017-12-20       Impact factor: 1.909

4.  Clinical Factors Associated with Low-Contrast Visual Acuity after Reduced-Fluence Photodynamic Therapy in Patients with Resolved Central Serous Chorioretinopathy and Good Baseline Visual Acuity.

Authors:  Aya Chubachi; Akiko Miki; Mayuka Hayashida; Mari Sakamoto; Hisanori Imai; Sentaro Kusuhara; Makoto Nakamura
Journal:  Pharmaceuticals (Basel)       Date:  2021-03-28
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.